Research and Development

Diagnostic Kits & Reagents

HA TECH is developing a range of testing kits and reagents for both laboratory and point of care testing, including for ‘COVID-19’. The company has launched a multi-gene target SARS-CoV-2 RT-PCR kit that is one of the fastest available globally.


Diagnostic Products under Development

1. RT-PCR Multiplex Combo kit for testing SARS-CoV-2, Influenza and RSV Virus


2. RT-PCR Multiplex Combo kit for differentiating Dengue, Chikungunya, Malaria and Zika virus


3. Rapid SARS-CoV-2 point of care test.


Research also begun for other Respiratory & STI Panels


Biopharmaceuticals and API

HA TECH is collaborating with a world leading research organization to develop biotherapeutic drugs. The company is developing a number of API products internally and via commercial partnership including: Cardiovascular, Antidiabetic, Anti-Ulcerant and Oncology drugs. The company is concentrating on the development of a key product range in Sydney and full-scale manufacturing in South East Asia, initially in Bangladesh.


Smart Materials and Technology

Stimulus responsive polymer hydrogel/microgels based products and applications are one of the key competencies of HA TECH. The company is developing devices and technologies for specific medical applications including for fertility treatments such as IVF.